EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring longitudinal relationships among Alzheimer's disease biomarkers

Benjamin Saef, Kellen K Petersen, Katherine Volluz, Yan Li, Duygu Tosun, Marta Mila-Aloma, Leslie M Shaw, Henrik Zetterberg, Jeffrey L Dage, Carrie E Rubel, Kyle Ferber, Lei Du-Cuny und 14 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Benjamin Saef und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, tau Proteins, Amyloid beta-Peptides. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie Inc., Alzheimer's Association, Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation, Biogen, Janssen Research & Development, LLC, and Ta…, NIA NIH HHS, the Foundation for the National Institutes of Health (FNIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION While most studies of Alzheimer's disease (AD) examine cross‐sectional relationships among biomarkers, longitudinal relationships are also highly relevant. METHODS This study in the Alzheimer's Disease Neuroimaging Initiative cohort ( n = 373) used non‐parametric Spearman correlations to explore the relationships of baseline values and rates of change in plasma biomarkers and rates of change in key AD outcomes. RESULTS Compared to rates of change of plasma biomarkers, baseline values of plasma biomarkers were more strongly associated with rates of change in key AD outcomes. Change in amyloid positron emission tomography (PET) was most strongly associated with baseline values of amyloid beta (Aβ)42/Aβ40 and phosphorylated tau (p‐tau)217, especially in amyloid PET–‐negative individuals. Changes in cortical thickness and measures of cognition were most strongly associated with baseline p‐tau217, especially in amyloid PET–positive individuals. DISCUSSION Baseline p‐tau217 is associated with rates of change of amyloid pathology and cognition. Visualization tools were developed to enable researchers to explore AD biomarker relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkerstau ProteinsAmyloid beta-PeptidesHumansPositron-Emission TomographyLongitudinal StudiesFemaleMaleAgedPeptide FragmentsBrain

Stichwörter der Autor:innen

Alzheimer's diseaseR shiny appblood biomarkersdata visualizationneuroimagingplasma biomarkers

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Northern California Institute for Research and Education, San Francisco, California, USA.
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

Förderung

  • AbbVie Inc., Alzheimer's Association, Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation, Biogen, Janssen Research & Development, LLC, and Ta…
  • NIA NIH HHS
  • the Foundation for the National Institutes of Health (FNIH)
  • Foundation for the National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Saef, B., Petersen, K. K., Volluz, K., Li, Y., Tosun, D., Mila-Aloma, M., Shaw, L. M., Zetterberg, H., Dage, J. L., Rubel, C. E., Ferber, K., Du-Cuny, L., Coomaraswamy, J., Baratta, M., Mordashova, Y., Saad, Z. S., Triana-Baltzer, G., Ashton, N. J., Meyers, E. A., …, & Schindler, S. E. (2026). Exploring longitudinal relationships among Alzheimer's disease biomarkers. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71711

Vancouver

Saef B, Petersen KK, Volluz K, Li Y, Tosun D, Mila-Aloma M, et al. Exploring longitudinal relationships among Alzheimer's disease biomarkers. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71711

BibTeX
@article{Saef2026,
  author = {Saef, Benjamin and Petersen, Kellen K and Volluz, Katherine and Li, Yan and Tosun, Duygu and Mila-Aloma, Marta and Shaw, Leslie M and Zetterberg, Henrik and Dage, Jeffrey L and Rubel, Carrie E and Ferber, Kyle and Du-Cuny, Lei and Coomaraswamy, Janaky and Baratta, Michael and Mordashova, Yulia and Saad, Ziad S and Triana-Baltzer, Gallen and Ashton, Nicholas J and Meyers, Emily A and Rosenbaugh, Erin G and Sabandal, J Martin and Bannon, Anthony W and Potter, William Z and Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimer's Disease Neuroimaging Initiative (ADNI) and Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in A…, Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in A… and Schindler, Suzanne E},
  title = {Exploring longitudinal relationships among Alzheimer's disease biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71711}
}
Kostenlos starten →